Is blood glucose monitoring still relevant? It seems to me that it very much is. As mentioned previously, not everyone yet has access to glucose monitoring sensors, so there are plenty of reasons to blood test. By Sue Marshall As well as whatever read more »

More than 50 patients in Denton, Manchester – many with diabetes – took part in a 12-week trial designed to help them shed pounds and significantly improve their health. The results found an average weight loss of 20lb and: • 72% reported a read more »

An international panel of diabetes experts has published guidelines for continuous glucose monitoring (CGM). Presented at the American Diabetes Association’s (ADA’s) 79th Scientific Sessions in San Francisco, the targets are for both research and clinical settings:   • People with Type 1 and Type 2 read more »

Insulet has won FDA clearance to market its Omnipod Dash alternate controller-enabled (ACE) infusion pump as an integrated insulin pump. The American company received FDA clearance for the Omnipod Dash in June 2018 and launched the device in early 2019. The latest indication read more »

Taking any excuse to get food on the front cover, it was fun to discover while working on a feature about summer’s food trends that someone has come up with advice on how to stop seagulls taking off with your chips. Thanks read more »

Hypo Awareness Week starts on Monday 30th September. You’ll know the feeling – trembling, sweating, cranky. But what about the people around you? Would they be able to spot the symptoms, so that they could help you out if needed? This Hypo read more »

FreeStyle Libre’s flash glucose monitoring system improves control in people with Type 1 diabetes during the first six months of use, says a nationwide audit. Presented at the American Diabetes Association’s 79th Scientific Session, the first milestone results of 1,299 people with Type read more »

Three years of follow-up from the COMISAIR study has found that glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method. Newly published in the journal Diabetes Care, the COMISAIR study, described as a read more »

Beta Bionics, based in the US, has announced the first patients have begun home use of dasiglucagon – a stable glucagon analogue – in a clinical trial of the company’s iLet bionic pancreas system for people with Type 1 diabetes. The iLet device features read more »

Abbott and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The companies are taking an innovative approach to connected care by developing tools that combine Abbott’s read more »